Jain Global LLC Sells 22,417 Shares of Waters Corporation $WAT

Jain Global LLC lowered its position in Waters Corporation (NYSE:WAT) by 26.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 63,281 shares of the medical instruments supplier’s stock after selling 22,417 shares during the quarter. Jain Global LLC owned about 0.11% of Waters worth $18,972,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in WAT. Brighton Jones LLC lifted its stake in Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after purchasing an additional 673 shares during the last quarter. Integrated Wealth Concepts LLC grew its position in Waters by 2.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after acquiring an additional 30 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Waters by 3.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after acquiring an additional 6,976 shares during the last quarter. Empowered Funds LLC increased its stake in Waters by 16.6% in the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after purchasing an additional 160 shares during the period. Finally, Sivia Capital Partners LLC bought a new stake in shares of Waters during the second quarter worth $232,000. 94.01% of the stock is owned by hedge funds and other institutional investors.

Waters Trading Up 1.1%

NYSE WAT opened at $286.42 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.27 and a current ratio of 1.73. The company has a market capitalization of $28.10 billion, a price-to-earnings ratio of 26.59, a price-to-earnings-growth ratio of 1.97 and a beta of 1.20. The company’s 50-day simple moving average is $352.67 and its two-hundred day simple moving average is $351.58. Waters Corporation has a one year low of $275.05 and a one year high of $414.15.

Waters (NYSE:WAT) last posted its quarterly earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 EPS for the quarter, beating the consensus estimate of $4.50 by $0.03. Waters had a net margin of 20.30% and a return on equity of 34.79%. The business had revenue of $932.36 million during the quarter, compared to analyst estimates of $928.17 million. During the same quarter in the previous year, the business posted $4.10 EPS. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. Equities analysts forecast that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on WAT. UBS Group cut their price target on shares of Waters from $395.00 to $370.00 and set a “neutral” rating on the stock in a report on Tuesday, February 10th. Barclays initiated coverage on shares of Waters in a research note on Tuesday, February 10th. They issued an “overweight” rating and a $400.00 target price on the stock. Evercore began coverage on shares of Waters in a research note on Tuesday, February 10th. They set a “hold” rating and a $360.00 price target for the company. Morgan Stanley lowered their price target on Waters from $423.00 to $350.00 and set an “equal weight” rating for the company in a report on Sunday, February 22nd. Finally, Robert W. Baird set a $363.00 price objective on Waters in a research note on Tuesday, February 10th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $393.84.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.